Reuters logo
BRIEF-Amphastar announces the receipt of a CRL for Intranasal Naloxone for the emergency treatment of opioid overdose
February 21, 2017 / 11:35 AM / 10 months ago

BRIEF-Amphastar announces the receipt of a CRL for Intranasal Naloxone for the emergency treatment of opioid overdose

Feb 21 (Reuters) - Amphastar Pharmaceuticals Inc

* Amphastar announces the receipt of a CRL for Intranasal Naloxone for the emergency treatment of opioid overdose

* Amphastar Pharmaceuticals Inc - CRL identifies issues including user human factors study, device evaluation, and other items that need to be addressed

* Amphastar Pharmaceuticals Inc - Will continue to offer Naloxone in pre-filled syringes while we pursue NDA for Intranasal Naloxone Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below